Increased cystatin C serum concentrations in patients with hepatic diseases of various severities
- 31 March 2004
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 341 (1-2) , 133-138
- https://doi.org/10.1016/j.cccn.2003.11.011
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Protease inhibitors of the sulfonamide type: Anticancer, antiinflammatory, and antiviral agentsMedicinal Research Reviews, 2003
- How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impactBMJ, 2001
- Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical ImplicationsOncology, 1997
- Tissue inhibitors of metalloproteinases in liver fibrosisThe International Journal of Biochemistry & Cell Biology, 1997
- Elevated Plasma Levels of Matrix Metalloproteinase–9 (92–Kd Type Iv Collagenase/Gelatinase B) in Hepatocellular CarcinomaHepatology, 1996
- Renal handling of radiolabelled human cystatin C in the ratScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Clinical evaluation of serum tissue inhibitor of metalloproteinases‐1 levels in patients with liver diseasesJournal of Gastroenterology and Hepatology, 1993
- Cystatin C and cathepsin B in human colon carcinoma: Expression by cell lines and matrix degradationInternational Journal of Cancer, 1992
- Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cerebrospinal fluid.Stroke, 1991
- Human cystatin, a new protein inhibitor of cysteine proteinasesBiochemical and Biophysical Research Communications, 1984